GROUP ONE TRADING, L.P. - 4D MOLECULAR THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

4D MOLECULAR THERAPEUTICS IN's ticker is and the CUSIP is 35104E950. A total of 2 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q2 2023$18,070
+20.5%
1,000
+42.9%
0.00%–
Q4 2021$15,000–700–0.00%–
 Download
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 400$50.00%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders